Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
CN Set to Optimize Volume-Based Procurement Rules, Strengthen Implementation of Results
Recommend 58 Positive 97 Negative 37 |
||||
|
||||
|
Since 2018, China has carried out 11 batches of national-level centralized volume-based drug procurement, covering 490 drugs, said Shi Zihai, deputy head of the National Healthcare Security Administration (NHSA). Going forward, the NHSA will focus on improving the price formation mechanism for centralized drug procurement in accordance with the recently issued opinions on improving this mechanism. Shi stressed that procurement rules will be optimized based on the characteristics of different categories of drugs, and efforts will be made to strengthen the implementation of selected procurement results. Auto-translated by AI This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
